|No Of Investors
|MIG Capital, and Munich office
Germanybased Temedica 25M Series By MIG Capital
Germany based Temedica a Health company raised €25 million additionally in series B by MIG Capital and Munich office. After this round, the total money raised to date is €42 million.
CEO Gloria Seibert told FinSnip that the company is planning to use these funds to provide personalized medicines according to the person.
Temedica is a tech-enabled health company that diagnoses millions of patients’ data by linking it with their health profiles like pharmacy apps, medical tests, and so on.
Moreover, users can cn check the medicine data, their expiry, advance booking tests and medicine, symptoms reports, disease progression, etc in a single dashboard.
Nyra handles business research, writing financial documents, news items, articles, and study materials about finances.